The Quality of Life of Mothers of Children With Food Allergy

NCT ID: NCT04740632

Last Updated: 2022-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-10

Study Completion Date

2023-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Food allergy (FA) derives from an abnormal immunological response to dietary antigens. On the basis of the immunological mechanism, FA are divided into the following forms: IgE-mediated, non-IgE-mediated and mixed. Prevalence, persistence and severity of pediatric FA have significantly increased over the past 2 decades. The treatment of FA is based on a rigorous elimination diet and on the correct management of acute allergic reactions, induced by the accidental ingestion of food allergens, with antihistamines, cortisones and adrenaline. Ensuring a strict exclusion of the allergen from the diet can be problematic, with the risk of nutritional deficiencies, accidental exposure, cross-contamination or caused by incorrect labeling of processed food products. At the same time, the daily management of a correct elimination diet and a possible allergic reaction, entail a significant burden and high levels of anxiety and stress associated with uncertainty about the management of anaphylaxis, in the parents of children with FA, particularly in mothers, resulting in an impact on Quality of Life (QoL). The availability of a multidisciplinary team made up of pediatricians, allergists and dietitians / nutritionists with experience in the field of FA could reduce the stress and anxiety of parents, while improving their QoL. Currently, for the evaluation of the quality of life of the parent of a child with FA, specific questionnaires for food allergies developed and validated in English are used: the food allergy self-efficacy scale for parents (FASE-P) and the Food Allergy Quality of Life - Parental Burden Questionnaire (FAQL-PB).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Food Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mothers of children with food allergy diagnosed by a multidisciplinary team

Mothers of children with food allergy diagnosed by a multidisciplinary team (Group 1) already followed for at least 6 months by the Tertiary Center of Pediatric Allergology..

Group Type NO_INTERVENTION

No interventions assigned to this group

Mothers of children with food allergy diagnosed by a non-multidisciplinary team

Mothers of children with food allergy diagnosed by a non-multidisciplinary team who plan to visit for the first time the Tertiary Center of Pediatric Allergology.

Group Type EXPERIMENTAL

Personalized Nutritional Counseling by a multidisciplinary team

Intervention Type BEHAVIORAL

Active diet therapy, instructions on reading labels, cross-contamination, allergen-free, foods recipes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Personalized Nutritional Counseling by a multidisciplinary team

Active diet therapy, instructions on reading labels, cross-contamination, allergen-free, foods recipes

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult mother of a patient \<12 years of age diagnosed with FA

Exclusion Criteria

* Mother's age \<18 years
* Mother unable to understand Italian
* Mother suffering from chronic diseases
* Mother suffering from epilepsy
* Mother suffering from neoplasms
* Mother suffering from immunodeficiencies
* Mother suffering from chronic infections
* Mother suffering from autoimmune diseases
* Mother suffering from inflammatory bowel diseases
* Mother suffering from functional gastrointestinal disorders
* Mother suffering from celiac disease
* Mother suffering from genetic-metabolic diseases
* Mother suffering from tuberculosis
* Mother suffering from congenital heart disease
* Mother suffering from tuberculosis
* Mother suffering from cystic fibrosis
* Mother suffering from other chronic pulmonary diseases
* Mother suffering from major malformations
* Mother suffering from previous surgery of the cardiovascular / respiratory / gastrointestinal tract
* Mother suffering from diabetes
* Mother suffering from neuropsychiatric and neurological disorders
* Mother suffering from eosinophilic disorders of the gastrointestinal tract
* Mother not living with her child with FA
* Concomitant presence in the child with FA of chronic diseases
* Concomitant presence in the child with FA of epilepsy
* Concomitant presence in the child with FA of neoplasms
* Concomitant presence in the child with FA of immunodeficiencies
* Concomitant presence in the child with FA of chronic infections
* Concomitant presence in the child with FA of autoimmune diseases
* Concomitant presence in the child with FA of inflammatory bowel diseases
* Concomitant presence in the child with FA of functional gastrointestinal disorders
* Concomitant presence in the child with FA of celiac disease
* Concomitant presence in the child with FA of genetic-metabolic diseases
* Concomitant presence in the child with FA of tuberculosis
* Concomitant presence in the child with FA of congenital heart disease
* Concomitant presence in the child with FA of tuberculosis
* Concomitant presence in the child with FA of cystic fibrosis
* Concomitant presence in the child with FA of other chronic lung diseases
* Concomitant presence in the child with FA of major malformations
* Concomitant presence in the child with FA of previous surgeries of the cardiovascular / respiratory / gastrointestinal tract
* Concomitant presence in the child with FA of diabetes
* Concomitant presence in the child with FA of neuropsychiatric and neurological disorders
* Concomitant presence in the child with FA of eosinophilic diseases of the gastrointestinal tract
* Concomitant presence in the child with FA of allergic diseases other than FA.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federico II University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roberto Berni Canani, MD, PhD

Associate professor- Chief of the Pediatric Allergy Program at the Department of Traslational Medical Science

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Traslational Medical Science - University of Naples Federico II

Naples, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Roberto Berni Canani, MD, PhD

Role: CONTACT

0817462680

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Roberto Berni Canani, MD, PhD

Role: primary

0817462680

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

283/20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improved Diagnostics in Food Allergy Study
NCT06097572 ENROLLING_BY_INVITATION NA